BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19084272)

  • 41. [The biological importance of C-reactive proteins in non-specific defense mechanisms].
    Sölter J; Uhlenbruck G
    Immun Infekt; 1982 Jul; 10(4):130-5. PubMed ID: 6752003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
    Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
    J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Aggregation of C-reactive protein in solutions at acid pH].
    Blizniukov OP; Kozmin LD; Falikova VV; Martynov AI; Tishchenko VM
    Biofizika; 2003; 48(5):844-52. PubMed ID: 14582409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein A--a new ligand for human C-reactive protein.
    Das T; Mandal C; Mandal C
    FEBS Lett; 2004 Oct; 576(1-2):107-13. PubMed ID: 15474020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemonchus contortus calreticulin binds to C-reactive protein of its host, a novel survival strategy of the parasite.
    Suchitra S; Anbu KA; Rathore DK; Mahawar M; Singh BP; Joshi P
    Parasite Immunol; 2008; 30(6-7):371-4. PubMed ID: 18422872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond.
    McFadyen JD; Zeller J; Potempa LA; Pietersz GA; Eisenhardt SU; Peter K
    Subcell Biochem; 2020; 94():499-520. PubMed ID: 32189313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of C-reactive protein binding to phosphatidyl choline by CZE and ESI-mass analysis.
    Peng YN; Ho YL; Wu CY; Liu MY
    Electrophoresis; 2009 May; 30(9):1564-71. PubMed ID: 19425005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system.
    Manderson GA; Martin M; Onnerfjord P; Saxne T; Schmidtchen A; Mollnes TE; Heinegård D; Blom AM
    Mol Immunol; 2009 Oct; 46(16):3388-98. PubMed ID: 19674792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformational Changes in C-Reactive Protein Affect Binding to Curved Membranes in a Lipid Bilayer Model of the Apoptotic Cell Surface.
    Alnaas AA; Moon CL; Alton M; Reed SM; Knowles MK
    J Phys Chem B; 2017 Mar; 121(12):2631-2639. PubMed ID: 28225631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [C-reactive protein: structure, properties, and methods of isolation].
    Zotova EG; Mysiakin EB; Toksambaeva SZh; Rubtsov KS; Serebrennikova GA
    Bioorg Khim; 1995 Oct; 21(10):739-51. PubMed ID: 8573206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Competitive binding of pentraxins and IgM to newly exposed epitopes on late apoptotic cells.
    Ciurana CL; Hack CE
    Cell Immunol; 2006 Jan; 239(1):14-21. PubMed ID: 16643876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New ligands for human C-reactive protein: calcium-dependent binding with epsilon-aminocaproic acid-agarose and calcium-independent binding with omega-aminohexyl-agarose.
    Kuwajima S; Kishida T; Noda T; Izumi Y; Naka K; Matsui T; Okuda K
    Int J Tissue React; 1990; 12(2):71-6. PubMed ID: 2210970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathophysiological condition changes the conformation of a flexible FBG-related protein, switching it from pathogen-recognition to host-interaction.
    Zhang J; Yang L; Anand GS; Ho B; Ding JL
    Biochimie; 2011 Oct; 93(10):1710-9. PubMed ID: 21689722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Binding reactivity of C-reactive protein for polycations. II. Modulatory effects of calcium and phosphocholine.
    Potempa LA; Siegel JN; Gewurz H
    J Immunol; 1981 Oct; 127(4):1509-14. PubMed ID: 7276568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
    Wittenbrink M; Spreu J; Steinle A
    Eur J Immunol; 2009 Jun; 39(6):1642-51. PubMed ID: 19424970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional Transformation of C-reactive Protein by Hydrogen Peroxide.
    Singh SK; Thirumalai A; Pathak A; Ngwa DN; Agrawal A
    J Biol Chem; 2017 Feb; 292(8):3129-3136. PubMed ID: 28096464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of acidic pH-dependent ligands of pentameric C-reactive protein.
    Hammond DJ; Singh SK; Thompson JA; Beeler BW; Rusiñol AE; Pangburn MK; Potempa LA; Agrawal A
    J Biol Chem; 2010 Nov; 285(46):36235-44. PubMed ID: 20843812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan.
    Aoyama E; Hattori T; Hoshijima M; Araki D; Nishida T; Kubota S; Takigawa M
    Biochem J; 2009 May; 420(3):413-20. PubMed ID: 19298220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
    Fabijanić D; Banić M; Kardum D; Sutlić Z; Simunić M; Bonacin D; Romić Z; Petricusić L; Kujundzić M
    Med Sci Monit; 2009 Feb; 15(2):CR45-50. PubMed ID: 19179966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C-reactive protein elicits white blood cell activation in humans.
    Bisoendial RJ; Birjmohun RS; Akdim F; van 't Veer C; Spek CA; Hartman D; de Groot ER; Bankaitis-Davis DM; Kastelein JJ; Stroes ES
    Am J Med; 2009 Jun; 122(6):582.e1-9. PubMed ID: 19486722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.